Friday April 21st is Acute Myeloid Leukaemia (AML) World Awareness Day 2017 and 'kNOw AML' are launching a global awareness campaign called 'Fight AML'
The Fight AML campaign aims to increase awareness of the support, resources, and care available in AML to patients, families, and healthcare professionals worldwide.
The mission is to improve education and support in order to empower the AML community in its fight against AML. The campaign portrays empowered patients, families, and doctors with their sleeves rolled up ready for their fight against AML. The Fight AML campaign will be shared globally by kNOw AML advocates through various channels in 2017 and into 2018.
Further information about the campiagn can be found on the website: www.know-aml.com.
The expanded Centre for Clinical Haematology at the Queen Elizabeth Hospital in Birmingham will help lead the global fight to eradicate all forms of blood cancer, including AML and Cure Leukaemia is committed to raising an additional £1m by December 31st 2017 to ensure the £3.2m project is fully funded.
Work on this transformational project is due to begin on May 15th and donations towards Cure Leukaemia's £1m Centre Appeal can be made via the dedicated JustGiving page HERE.
Cure Leukaemia has produced a brochure (left) detailing the global importance of this expanded Centre which can be viewed and downloaded HERE.
Two patients currently battling AML thanks to groundbreaking treatements made available thanks to Cure Leukaemia's funding are 28-year-old Elizabeth Dean and 49-year-old Deborah Harkins:
"I was diagnosed with Acute Myeloid Leukaemia in 2014. After relapsing twice following intensive chemotherapy and also after a bone marrow transplant, my chances of a cure were gone and I was given a few months to live. I was given hope when I was placed on a clinical trial at the Centre of Clinical Haematology.
This was not available anywhere else in the world. Recently I was told that I am now in remission following three cycles of chemotherapy on the trial. The main doctor and specialist nurse supervising my care are funded by Cure Leukaemia, thanks to whom, I've been given a fresh spark of hope and potentially another chance at life."
Elizabeth Dean - March 2017
“My life was turned upside down when I was diagnosed with high risk AML in 2016. A bone marrow transplant was my only option and for most people, even with this procedure, the outcome is rarely positive. However, thanks Cure Leukaemia's funding I have been given access to a clinical trail named FIGARO to improve those odds.
This is one of the only Centres in the world at which this groundbreaking treatment is available and without access to this trial I probably wouldn’t be here now.”
Deborah Harkins - March 2017
Cure Leukaemia's £1m Centre Appeal 2017